HomeMarket NewsMicro Cap StocksWhy Glimpse Group Shares are Experiencing a 41% Drop; Pre-market Movers Revealed

Why Glimpse Group Shares are Experiencing a 41% Drop; Pre-market Movers Revealed

Actionable Trade Ideas

always free

Table of Contents hide

image31

Gainers

  • RVL Pharmaceuticals plc (Ticker: RVLP) saw a significant rise of 181.8% in pre-market trading, reaching $0.2201.
  • Novo Integrated Sciences, Inc. (Ticker: NVOS) experienced a surge of 86% to $0.3739 in pre-market trading. The company signed a One Billion Dollar Master Collateral Transfer Agreement with Blacksheep Trust for monetization purposes.
  • Polished.com Inc. (Ticker: POL) witnessed a surge of 35% to $0.1060 in pre-market trading. The company plans to hold a special meeting of stockholders to approve a reverse stock split.
  • OpGen, Inc. (Ticker: OPGN) gained 34.3% in pre-market trading, reaching $0.27.
  • Brooge Energy Limited (Ticker: BROG) rose 23% to $6.64 in pre-market trading after a 7% increase on Thursday.
  • iSun, Inc. (Ticker: ISUN) gained 18.3% to $0.2550 in pre-market trading. The company recently filed for an offering of up to 10.96 million shares of common stock.
  • T2 Biosystems, Inc. (Ticker: TTOO) rose 17.2% to $0.2090 in pre-market trading.
  • OPKO Health, Inc. (Ticker: OPK) jumped 12% to $1.68 in pre-market trading. The company’s ModeX Therapeutics was awarded a BARDA Contract to develop novel multispecific antibodies against viral infectious disease threats.
  • Better Therapeutics, Inc. (Ticker: BTTX) rose 10.1% to $0.3791 in pre-market trading. Better Therapeutics completed enrollment in a real-world evidence program evaluating the long-term effectiveness of AspyreRx in Type 2 Diabetes.
  • NIKE, Inc. (Ticker: NKE) climbed 8.1% to $96.87 in pre-market trading following positive quarterly earnings.

Losers

  • The Glimpse Group, Inc. (Ticker: VRAR) plummeted 41.2% to $1.91 in pre-market trading after reporting a wider loss for FY23.
  • Tonix Pharmaceuticals Holding Corp. (Ticker: TNXP) fell 36.8% to $0.4418 in pre-market trading after pricing a $4.5 million public offering.
  • Vaccinex, Inc. (Ticker: VCNX) shares dropped 29.8% to $1.06 in pre-market trading following the pricing of a $9.6 million public offering.
  • Bionomics Limited (Ticker: BNOX) fell 15.7% to $2.84 in pre-market trading. The stock had surged 244% on Thursday after the ATTUNE trial showed promising results for the company’s BNC210 treatment in reducing PTSD symptom severity.
  • FLJ Group Limited (Ticker: FLJ) shares declined 14.7% to $0.1865 in pre-market trading after a 30% gain on Thursday.
  • ReShape Lifesciences Inc. (Ticker: RSLS) dropped 13.6% to $0.3802 in pre-market trading after a 15% dip on Thursday.
  • Femasys Inc. (Ticker: FEMY) fell 11.8% to $1.34 in pre-market trading after a 37% jump on Thursday. The company recently received FDA clearance for FemaSeed, an infertility treatment.
  • Baudax Bio, Inc. (Ticker: BXRX) experienced an 11.5% decline to $0.40 in pre-market trading. The company had gained over 50% on Thursday after receiving FDA orphan drug designation for TI-168 to treat Hemophilia A with inhibitors.
  • Quince Therapeutics, Inc. (Ticker: QNCX) fell 11.2% to $1.03 in pre-market trading. The company announced that the FDA has lifted a partial clinical hold on EryDel’s lead Phase 3 asset EryDex.
  • Ostin Technology Group Co., Ltd. (Ticker: OST) shares dropped 11% to $0.65 in pre-market trading after an 8% decline on Thursday.

For more market insights, read our article: Nike, Carnival, and 3 Other Stocks to Watch Heading Into Friday.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.